The COVID-19 pandemic exposed critical weaknesses in global health governance. Critically examine WHO's role and suggest reforms.

Q. The COVID-19 pandemic exposed critical weaknesses in global health governance. Critically examine WHO's role and suggest reforms. (15 marks, 250-350 words)

WHO characterised COVID-19 as a pandemic only on 11 March 2020, six weeks after declaring a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 [1][2]. That interval captures both WHO's reach as the world's alert system and its structural weakness — global responsibility paired with purely national authority.

Where WHO delivered - Early warning under IHR (2005): the PHEIC was declared when confirmed cases outside China were still few, ahead of most national responses [2]. - Technical public good: standardised case definitions, clinical management protocols, and neutral naming (SARS-CoV-2/COVID-19) that avoided geographic stigma [1]. - Equity architecture: COVAX pooled procurement for low-income states; India's Vaccine Maitri supplied over 30 crore doses to nearly 100 countries, partly routed through COVAX [5].

Where it failed - Delayed escalation: the Director-General himself cited "alarming levels of inaction" — the pandemic label arrived after community transmission was global [1]. - No enforcement teeth: IHR (2005) carried no penalty for delayed state notification or for travel bans imposed against WHO advice. - Dependence and opacity: reliance on member-supplied data and largely earmarked voluntary funding limited independent verification, notably on origins. - Equity collapse: vaccine nationalism accompanied a 3.5% global output contraction in 2020, the sharpest since the war, hitting the poorest hardest [4].

Reform agenda - Operationalise the IHR amendments (2024, in force September 2025) creating a higher "pandemic emergency" tier and mandatory National IHR Authorities [3]. - Ratify and finance the WHO Pandemic Agreement (adopted 20 May 2025), especially its Pathogen Access and Benefit-Sharing (PABS) system [6]. - Shift WHO to predictable assessed contributions, and permit verification of outbreak intelligence from non-state sources. - Strengthen domestic law: India's colonial Epidemic Diseases Act, 1897 was amended in 2020 only to protect health workers [7]; a comprehensive public health law remains pending.

Global health governance failed not for want of science but for want of compliance and equity. The 2024 IHR package and the 2025 Agreement supply the architecture; their worth now rests on ratification, assured financing and fair PABS implementation — the practical route to SDG-3 and to health as an integral part of the right to life.

(~340 words)

Sources: 1. WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020 — pandemic characterisation, "alarming levels of inaction", disease naming and response pillars 2. WHO Timeline – COVID-19 (archived) — PHEIC declared 30 January 2020; early outbreak chronology 3. Amended International Health Regulations enter into force (WHO, 19 September 2025) — "pandemic emergency" alert tier and National IHR Authorities 4. IMF World Economic Outlook Update, January 2021 — global output contraction of 3.5% in 2020 5. Export of Covid-19 Vaccines, Ministry of External Affairs / PIB — Vaccine Maitri supplies and COVAX contribution 6. World Health Assembly adopts historic Pandemic Agreement (WHO, 20 May 2025) — adoption of the Agreement and the PABS system 7. The Epidemic Diseases (Amendment) Ordinance, 2020 – PRS Legislative Research — 2020 amendment limited to protecting healthcare personnel